64
44
Growth Score
-6 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
273911
ERS Genomics is a biotechnology company to provide broad access to the foundational CRISPR-Cas9 intellectual property.
Shaun Foy: ChairmanPast Role: SR One, Venture Partner
Emmanuelle Charpentier: Scientific Advisor and Co-FounderPast Role: Umeå University, Professor
About the Company
ERS Genomics is a biotechnology company to provide broad access to the foundational CRISPR-Cas9 intellectual property. The CRISPR-Cas9 utilizes a molecular complex comprised of the protein Cas9 together with one or more guide RNAs which binds to the genome in living cells at any desired locations and also offers significant advantages in cost,
speed, efficiency over the earlier genome editing methods.
ERS Genomics was founded in 2014 and is headquartered in Dublin, Ireland.
